It is a chemicals and materials private limited company based in Udaipur, Rajasthan, India, established in 2012.
2012 | Udaipur, Rajasthan, India | ActiveSyngeny Pharmatech Private Limited, a active private limited company, was established on 26 April 2012 in Udaipur, Rajasthan, India. Engaging in industrial chemicals within the chemicals and materials sector, it holds CIN: U85100RJ2012PTC038700. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Formerly known as Manak Spinners Private Limited. It upholds a compliant status. Its leadership includes Swapnil Agrawal (Additional Director), Abhishek Jain (Additional Director). Past directors included Lalit Kumar Baregama, Rakesh Suhalaka, Meenakshi Suhalka. It holds ₹5.00 M open charges and ₹5.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 24-A, Agrasen Nagar, Udaipur, Rajasthan, 313001.
U85100RJ2012PTC038700
038700
26 April 2012
₹1.00 M
₹1.00 M
Roc Jaipur
Unlisted
Active
Explore comprehensive insights into Syngeny Pharmatech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Swapnil Agrawal | Additional Director | 10 Dec 2018 | Current |
| Abhishek Jain | Additional Director | 10 Dec 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Dec 2018 | Past |
| Pramod Abcsdd | Director | 10 Dec 2018 | Past |
| Pramod Abcsdd | Director | 10 Dec 2018 | Past |
| Pramod Abcsdd | Director | 10 Dec 2018 | Past |
| Pramod Abcsdd | Director | 10 Dec 2018 | Past |
| Pramod Abcsdd | Director | 10 Dec 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Syngeny Pharmatech Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 55.48% decrease. The company also saw a substantial improvement in profitability, with a 43.52% increase in profit. The company's net worth observed a substantial decline by a decrease of 12.14%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Syngeny Pharmatech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,000,000.00
₹5,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jul 2019 | Others | ₹5.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Syngeny Pharmatech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Syngeny Pharmatech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syngeny Pharmatech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 04 Jul 2019 via Charge ID 100280170 with Others was fully satisfied on 03 Apr 2025. was documented.
Progress on Syngeny Pharmatech Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Syngeny Pharmatech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur. was recorded as a recent event.
A charge with Others amounted to Rs. 5.00 M with Charge ID 100280170 was registered on 04 Jul 2019. was recorded as a recent event.
Progress on Swapnil Agrawal was appointed as a Additional Director was appointed as a Additional Director on 10 Dec 2018 & has been associated with this company since 7 years 3 days . was documented.
Progress on Abhishek Jain was appointed as a Additional Director was appointed as a Additional Director on 10 Dec 2018 & has been associated with this company since 7 years 3 days . was documented.
The CIN of Syngeny Pharmatech Private Limited is U85100RJ2012PTC038700.
Syngeny Pharmatech Private Limited is headquartered at 24-A, Agrasen Nagar, Udaipur, Rajasthan, 313001.
Syngeny Pharmatech Private Limited was incorporated on 26 April 2012.
The current directors of Syngeny Pharmatech Private Limited are
The primary industry of Syngeny Pharmatech Private Limited is Chemicals And Materials.
Syngeny Pharmatech Private Limited is unlisted.
The authorized capital of Syngeny Pharmatech Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Syngeny Pharmatech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX